Century Therapeutics, Inc.

IPSC

$2.11

+0.72%

N/A+$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Brent Pfeiffenberger	President, Chief Executive Officer & Chairman	USD 971,732		1978	Active
Gregory Russotti	Chief Technology & Manufacturing Officer	USD 789,960	—	1967	Active
Chad A. Cowan	Chief Scientific Officer	USD 760,539	—	1972	Active
Krista Kauppinen	VP, General Counsel & Head of Intellectual Property	—	—	—	Active
Michael Naso	Senior Vice President of Cell Engineering	—	—	—	Active
Megan Bilson	Chief People Officer	—		—	Active
Douglas Carr	Senior VP of Finance & Operations, Principal Financial Officer and Secretary	—		—	Active
Elizabeth Devlin	Vice President & Head of Development	—		—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Brent Pfeiffenberger, Pharm.D.,	President President, Chief Chief Executive Officer and Chairman of the Board	Founder / CEO	$640.63K	$0	$1.87M	$222.68K	$317.11K	$14.00K	$2.38M
2026-04-27	2025	Chad Cowan , Ph.D. ,	Chief Chief Scientific Officer	C-Level	$559.53K	$0	$398.33K	$8.33K	$201.01K	$0	$1.17M
2026-04-27	2025	Adrienne Farid, Ph.D.,	Former Former Chief Chief Development Officer	C-Level	$333.35K	$0	$71.12K	$51.24K	$0	$533.51K	$989.40K
2026-04-27	2025	Gregory Russotti, Ph.D.,	Chief Chief Technology and Manufacturing Officer and former former Interim President President and Chief Chief Executive Officer	Founder / CEO	$559.65K	$0	$71.12K	$51.24K	$226.66K	$3.65K	$912.32K
2026-04-27	2024	Brent Pfeiffenberger, Pharm.D.,	President President, Chief Chief Executive Officer and Chairman of the Board	Founder / CEO	$625.00K	$450.00K	$92.61K	$392.00K	$360.94K	$272.73K	$2.19M
2026-04-27	2024	Gregory Russotti, Ph.D.,	Chief Chief Technology and Manufacturing Officer and former former Interim President President and Chief Chief Executive Officer	Founder / CEO	$542.50K	$0	$127.56K	$547.41K	$256.33K	$13.80K	$1.49M
2026-04-27	2024	Adrienne Farid, Ph.D.,	Former Former Chief Chief Development Officer	C-Level	$513.05K	$0	$127.56K	$547.41K	$215.48K	$13.80K	$1.42M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of IPSC

RELATIONS

Upstream

FUJIFILM Cellular Dynamics (FCDI)TSE:4901Inscripta / Manus BioCatalent, Inc.NYSE:CTLT Thermo Fisher Scientific Inc.NYSE:TMO Bio-Techne CorporationNASDAQ:TECHSartorius AGETR:SRT3Lonza Group AGSWX:LONNAldevron (Danaher Corporation)NYSE:DHRPluristyx, Inc.

Downstream

Bristol Myers SquibbNYSE:BMYFriedrich-Alexander University Erlangen-Nuremberg (FAU)Versant VenturesLeaps by Bayer (Bayer AG)ETR:BAYN

Proxies

Fate Therapeutics, Inc.NASDAQ:FATEFUJIFILM Holdings CorporationTSE:4901Bayer AGETR:BAYNCRISPR Therapeutics AGNASDAQ:CRSP

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer